代谢途径的变化与口腔癌风险之间的关联:来自巴基斯坦病例控制研究的结果
Arifa Shabbir1, Muhammad Usman Rashid2, Ezzat M Awad3
1Department of Zoology, GC University, Lahore, Pakistan.
Molecular biology reports
|November 19, 2024
概括
在巴基斯坦,关键代谢基因的遗传变异与口腔癌 (OC) 风险无关. 然而,OC患者中COX2,HIF1α和SOD2蛋白质水平的变化表明,其他调节因素也参与了口腔癌的发展.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 口腔癌 (OC) 构成了重大的全球健康挑战,巴基斯坦的发病率在全球排名第五.
- 由于OC的预后不佳,早期检测至关重要.
- 遗传因素,包括代谢基因中的单核酸多态 (SNP),是OC易感性的潜在贡献者.
研究的目的:
- 调查CYP1A1,COX2,SOD2和HIF1a基因中的SNP与巴基斯坦人口口腔癌风险之间的联系.
- 分析这些基因在口腔癌患者和对照中的蛋白质表达水平.
主要方法:
- 一项前性研究涉及215名新诊断的口腔癌患者和410名对照人群.
- 使用高分辨率化 (HRM) 分析和桑格测序分析的遗传变异.
- 使用酶相关免疫吸收试验 (ELISA) 评估的蛋白质表达.
主要成果:
- 研究SNP与口腔癌风险之间没有发现显著的关联.
- 一个不显著的趋势表明SOD2变体 (rs4880) G等位基因可能会增加OC风险.
- 与对照组相比,在口腔癌患者中观察到高的COX2和HIF1α蛋白水平和降低的SOD2水平.
结论:
- 虽然特定的SNP与OC风险没有显著关联,但COX2,HIF1α和SOD2的蛋白质表达变化表明其他调节机制参与其中.
- 对转录后修饰和表观遗传因素的进一步研究可能会揭示巴基斯坦口腔癌的新生物标志物和治疗点.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.7K


